Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target

Jaap Verweij, Ole S. Nielsen, John Radford et al.|European Journal of Cancer|2003

Cited by 403